Livent (NYSE: LTHM) is one of 27 publicly-traded companies in the “Chemicals & allied products” industry, but how does it compare to its competitors? We will compare Livent to related companies based on the strength of its profitability, earnings, analyst recommendations, institutional ownership, valuation, risk and dividends.
This table compares Livent and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current recommendations and price targets for Livent and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Livent presently has a consensus target price of $15.08, suggesting a potential upside of 117.34%. As a group, “Chemicals & allied products” companies have a potential upside of 20.44%. Given Livent’s higher possible upside, equities research analysts plainly believe Livent is more favorable than its competitors.
Institutional & Insider Ownership
98.0% of Livent shares are held by institutional investors. Comparatively, 72.3% of shares of all “Chemicals & allied products” companies are held by institutional investors. 0.7% of Livent shares are held by insiders. Comparatively, 8.9% of shares of all “Chemicals & allied products” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Livent and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Livent||$442.50 million||$126.10 million||7.63|
|Livent Competitors||$7.43 billion||$509.65 million||12.61|
Livent’s competitors have higher revenue and earnings than Livent. Livent is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Livent competitors beat Livent on 8 of the 12 factors compared.
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. Livent Corporation was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.